Navigation Links
Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint

egulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson 's Annual Report on Form 10-K for the fiscal year ended January 1, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov or on request from Johnson & Johnson. Johnson & Johnson assumes no obligation to update any forward-looking statements as a result of new information or future events or development.

CONTACT: Chris Ernst, +1-650-564-4131, cell +1-415-710-9445,, Katherine Stueland, cell +1-312-208-0320,, both for Scios Inc. cernst1@alzus.jnj.com kstueland@weisscommpartners.com

Web site: http://www.sciosinc.com/http://www.natrecor.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/25/2009)...rstCall/--AmericanScientificResourcesInc.(PinkShee...aveopenedaregionalmarketingandproductionmanagement...realocationabroad,providinganessentialgatewayforth...ndsafetyproductsforchildrenandadultstobedistribute...yinthestateofOhiowheretheywillalsobeabletodosubcom...
(Date:11/25/2009).../PRNewswire/-- FromNovember16-18,Phonak,theleading...thesecondeditionoftheHearingCareforAdultsConferenc...econferencebroughttogetherleadingexpertsinagingand...swhoworkeverydaywitholderpeoplewithhearinglossfora...esearchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...wire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAme...aythatitreceivedtheEnvironmentalResponsibilityandS...lSummit,sponsoredbytheCaliforniaManufacturersandTe...alAssociation(IEA)andtheChemicalIndustryCouncilofC...iousawardavailablefromallthreeorganizationsandgain...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 1Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 2Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 3Drinking Wine Is Good For The 26quot 3BHeart 26quot 3B 26amp 3B Environment 51574 1Drinking Wine Is Good For The 26quot 3BHeart 26quot 3B 26amp 3B Environment 51574 2Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 1Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 2Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 3Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 4
... WIRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIAC)...Chief Executive Officer of ViaCell, will present a...peline at the C.E. Unterberg,Towbin Emerging Grow...007 at 3:00 p.m. at the Mandarin Oriental Hotel in...ation will be available on,the Investor Informatio...
...2007 (PrimeNewswire via COMTEX News,Network) -- Ge...,leader in drug delivery for metabolic diseases th...ay that it will be making three,poster presentatio...ety of Pediatric Endocrinology in Helsinki, Finlan...ttp://www.espe2007.org/">www.espe2007.org ). , , ,...
Other Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... NEUILLY-SUR-SEINE,France,Nov.27/PRNewswire/--Team...ingteamdedicatedtoethicalsportinganddevelopingthen...itwillbecomeTeamGarmin-Transitionswiththeadditiono...onsOpticalistheworld,sleadingmanufacturerofadaptiv...logyinthewidestselectionofspectaclelensessuchasTra...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ent an important contribution to future clinical t...the prestigious science journal Nature and will ...on the molecular mechanisms of hematopoiesis, whic...n Munich at the international symposium "Molecular...
...sAbilities Resources champions company,s efforts ,...ed the 2009 Disability Matters Award in the catego...ment to supporting people with disabilities and th...and its employee network group, Sodexo Organizatio...
... to treat a mid-level, common injury , , ROSEMON...ions can commonly be treated nonsurgically and hig...re review published in the April 2009 issue of the...se injuries that fall in between. , , , , ...
... Immunotech Laboratories, Inc. , , Immunotech La...DART conference in Puerto Rico with its abstract ...ificant antiretroviral activity via specific novel...ence on Clinical and Social Research on AIDS and D...
... Awareness among Hispanic Community as Fewer Recei...Easter Seals is shining the spotlight on its servi...vast array of services, the national nonprofit pro...ren and adults with autism the organization serves...
..., Self-administered Alternative to Injections for ... LAKE, N.J., April 1 Strativa Pharmaceuticals, th...subsidiary of Par Pharmaceutical Companies, Inc. (...Nasal Spray is an FDA approved prescription vitami...
Other Medicine News:Health News:Last step leading to blood cell formation elucidated 2Health News:Sodexo Receives 2009 Disability Matters Award 2Health News:Sodexo Receives 2009 Disability Matters Award 3Health News:Healing a Shoulder Separation 2Health News:Healing a Shoulder Separation 3Health News:Beating a Global Killer: HIV/AIDS 2Health News:Beating a Global Killer: HIV/AIDS 3Health News:Beating a Global Killer: HIV/AIDS 4Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 2Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 4
...BAK/C cervical interbody fusion system represents ...ive disc disease of the cervical spine. The system...ration, and implantation. The self-packing of bone...raft, eliminating the need to harvest from the ili...
Intera 3.0T
...The Intradiscal Instruments are designed to provid...sc removal, endplate preparation, and insertion of...tebral Spreaders, Intradiscal Wedges, Spanners, Ne...er. Used in ALIF (Anterior Thoracic Interbody Fusi...
...Symphony II Platelet Concentrate System is a point... of Platelet Concentrate (also referred to as Plat...PPP) from a small sample of blood. The Symphony II...s, which are found in the platelets. The platelet ...
Medicine Products: